Affinity Asset Advisors »

Research Alliance Corp Iii shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.0M 370k 10.70

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii